Fingerprint
Dive into the research topics of 'A phase I dose-escalation and expansion study of telaglenastat in patients with advanced or metastatic solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I dose-escalation and expansion study of telaglenastat in patients with advanced or metastatic solid tumors
James J. Harding, Melinda Telli, Pamela Munster, Martin H. Voss, Jeffrey R. Infante, Angela DeMichele, Mark Dunphy, Mai H. Le, Chris Molineaux, Keith Orford, Frank Parlati, Sam H. Whiting, Mark K. Bennett, Nizar M. Tannir, Funda Meric-Bernstam
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations